Brenus Pharma

Brenus PharmaBrenus Pharma
Brenus Pharma

Brenus Pharma

Clinical-stage immunotherapy company developing novel treatments for cancer.

Website
Active29Lyon, France
Rate
Advertise here

About

Brenus Pharma is a biotechnology company focused on developing innovative in-vivo immunotherapies for cancer treatment. Their lead candidate, STC-1010, is in clinical development for MSS mCRC. The company leverages a proprietary platform for multi-asset expansion.
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Brenus Pharma do?

Brenus Pharma is a biotechnology company focused on developing innovative in-vivo immunotherapies for cancer treatment. Their lead candidate, STC-1010, is in clinical development for MSS mCRC. The company leverages a proprietary platform for multi-asset expansion.

How much funding has Brenus Pharma raised?

Brenus Pharma has raised a total of $13M in funding. The most recent round on record is Series A.

Where is Brenus Pharma headquartered?

Brenus Pharma is headquartered in Lyon, France.

What industry does Brenus Pharma operate in?

Brenus Pharma operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, Drug Discovery, Clinical Trials.

How many employees does Brenus Pharma have?

Brenus Pharma has approximately 29 people on record.

What is Brenus Pharma's revenue?

StartupHub estimates Brenus Pharma's annual revenue at $2.9M (range $1.6M to $8.7M, 69% confidence), based on comparable companies in the sector.

What is Brenus Pharma's valuation?

StartupHub estimates Brenus Pharma's effective valuation at $49.6M (range $31.5M to $75.6M, 25% confidence), based on comparable companies in the sector.